LU86901A1 - Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale - Google Patents

Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale Download PDF

Info

Publication number
LU86901A1
LU86901A1 LU86901A LU86901A LU86901A1 LU 86901 A1 LU86901 A1 LU 86901A1 LU 86901 A LU86901 A LU 86901A LU 86901 A LU86901 A LU 86901A LU 86901 A1 LU86901 A1 LU 86901A1
Authority
LU
Luxembourg
Prior art keywords
pharmaceutical composition
composition according
polypeptide
sms
ether
Prior art date
Application number
LU86901A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2138/86A external-priority patent/CH667994A5/de
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86901A1 publication Critical patent/LU86901A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
LU86901A 1986-05-27 1987-05-26 Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale LU86901A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH213886 1986-05-27
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.
CH214486 1986-05-27
CH214486 1986-05-27

Publications (1)

Publication Number Publication Date
LU86901A1 true LU86901A1 (fr) 1987-12-16

Family

ID=25689611

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86901A LU86901A1 (fr) 1986-05-27 1987-05-26 Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale

Country Status (21)

Country Link
US (1) US5393738A (no)
KR (1) KR870010870A (no)
AU (1) AU601740B2 (no)
BE (1) BE1000722A4 (no)
CA (1) CA1299495C (no)
DE (1) DE3716437A1 (no)
DK (1) DK265587A (no)
ES (1) ES2008126A6 (no)
FI (1) FI872313A (no)
FR (2) FR2599254B1 (no)
GB (1) GB2190838B (no)
GR (1) GR870820B (no)
HU (1) HU198626B (no)
IL (1) IL82645A0 (no)
LU (1) LU86901A1 (no)
MY (1) MY101233A (no)
NL (1) NL8701143A (no)
NO (1) NO171484C (no)
NZ (1) NZ220418A (no)
SE (1) SE8702188L (no)
WO (1) WO1987007149A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3845000C2 (de) * 1987-07-10 1998-11-19 Novartis Ag Anwendung von Octreotid zur Behandlung von Brustkrebs
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
FR2668933B1 (fr) * 1990-06-15 1995-05-05 Sandoz Sa Composition pharmaceutique a base de somatostatine.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
DE19949897A1 (de) * 1999-10-15 2001-04-19 Rainer Rogasch Formkörper und Verfahren zu dessen Herstellung
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
DK1787658T3 (da) 2005-11-10 2012-06-25 Chemi Spa Formuleringer med forsinket frigørelse og indeholdende somatostatin-analoge væksthormoninhibitorer
SI2343982T1 (sl) * 2008-09-17 2017-08-31 Chiasma Inc. Farmacevtski sestavki in metode povezane z dostavo
AU2015201581B2 (en) * 2008-09-17 2017-03-09 Amryt Endo, Inc. Pharmaceutical Compositions and Related Methods of Delivery
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
CA2784120A1 (en) 2009-12-16 2011-07-14 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
CA2970519A1 (en) 2014-12-10 2016-06-16 Chiasma Inc. Oral octreotide administered in combination with other therapeutic agents
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1062898A (en) * 1912-12-09 1913-05-27 Fred Drew Automobile.
GB1062898A (en) * 1963-06-14 1967-03-22 Evans Medical Ltd Pharmaceutical compositions containing protamines
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4041155A (en) * 1974-10-29 1977-08-09 American Home Products Corporation Long acting somatostatin composition
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
DK506476A (da) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Farmaceutiske preparater til behandling af calciumstofs skifteforstyrrelser
US4093574A (en) * 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4087390A (en) * 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
DK144731C (da) * 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4230695A (en) * 1976-08-02 1980-10-28 Vitose Corporation Enhanced protein assimilation with fructose
JPS5920647B2 (ja) * 1976-10-01 1984-05-15 武田薬品工業株式会社 注射剤
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
CA1107273A (en) * 1978-05-19 1981-08-18 Chester A. Meyers Somatostatin analogs having a substituted tryptophyl residue in position eight
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
JPS57118509A (en) * 1981-01-14 1982-07-23 Toyo Jozo Co Ltd Novel preparation of high absorbability
JPS57146723A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS57146722A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
SE460638B (sv) * 1981-01-14 1989-11-06 Toyo Jozo Kk Suppositoriepreparat med foerbaettrad absorptionsegenskap
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
JPS58500563A (ja) * 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
WO1983000288A1 (en) * 1981-07-17 1983-02-03 Balschmidt, Per A stable aqueous, therapeutic insulin preparation and a process for preparing it
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS61500439A (ja) * 1983-11-21 1986-03-13 リ−ジエンツ　オヴ　ザ　ユニヴア−シテイ−　オヴ　ミネソタ 慢性的非経口ホルモン投与用緩衝化ポリオ−ル−ホルモン混合物
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides

Also Published As

Publication number Publication date
SE8702188D0 (sv) 1987-05-25
FR2630916A1 (fr) 1989-11-10
KR870010870A (ko) 1987-12-18
CA1299495C (en) 1992-04-28
SE8702188L (sv) 1987-11-28
AU7336487A (en) 1987-12-03
GB2190838A (en) 1987-12-02
WO1987007149A1 (en) 1987-12-03
NO171484C (no) 1993-03-24
BE1000722A4 (fr) 1989-03-21
DK265587D0 (da) 1987-05-25
NZ220418A (en) 1990-07-26
ES2008126A6 (es) 1989-07-16
NO872174L (no) 1987-11-30
HUT43956A (en) 1988-01-28
DE3716437A1 (de) 1987-12-03
FR2599254A1 (fr) 1987-12-04
AU601740B2 (en) 1990-09-20
DK265587A (da) 1987-11-28
GB2190838B (en) 1990-12-12
NO171484B (no) 1992-12-14
NO872174D0 (no) 1987-05-25
FR2630916B1 (fr) 1993-10-22
MY101233A (en) 1991-08-17
FI872313A (fi) 1987-11-28
HU198626B (en) 1989-11-28
US5393738A (en) 1995-02-28
GR870820B (en) 1987-09-25
GB8712193D0 (en) 1987-06-24
FR2599254B1 (fr) 1989-12-01
NL8701143A (nl) 1987-12-16
IL82645A0 (en) 1987-11-30
FI872313A0 (fi) 1987-05-25

Similar Documents

Publication Publication Date Title
LU86901A1 (fr) Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale
BE1005236A3 (fr) Compositions pharmaceutiques a base de cyclosporines.
FR2737121A1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
EP2124961B1 (fr) Nouvelle composition à base d'oxime de cholest-4-èn-3-one
EP0862423B1 (fr) Composition pharmaceutique pour administration par voie orale
CH679011A5 (no)
FR2642650A1 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines
CH680567A5 (no)
CA2470443A1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
WO2002047660A1 (fr) Composition pharmaceutique de dronedarone pour administration parenterale
FR2663227A1 (fr) Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree.
EP0927026A1 (fr) Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
CH661436A5 (fr) Compositions de nifedipine administrables par voie rectale et procedes pour leur fabrication.
FR2467596A1 (fr) Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
EP0356325B1 (fr) Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glycéride gélifié par au moins un polymère cellulosique
LU85812A1 (fr) Forme dosee d'etoposide a usage oral
CA1059913A (fr) Compositions pharmaceutiques
EP0483320B1 (fr) Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
FR2649322A1 (fr) Complexes biodisponibles d'acide (alpha)-linolenique, extraits de plantes en contenant et compositions pharmaceutiques les incorporant
FR2823M (no)
EP2303243B1 (fr) Composition orale contenant du clopidogrel sous forme de base
FR2641971A1 (fr) Composition pharmaceutique antihypertensive associant le benazepril et un diuretique thiazidique
FR2805992A1 (fr) Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
FR2558728A1 (fr) Composition pharmaceutique antipaludeenne a base de quinine, quinidine et cinchonine